☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
moderna
Moderna’s mRESVIA (mRNA-1345) Vaccine Gains the EC’s Approval to Prevent Lower Respiratory Tract Disease (LTRD)
August 27, 2024
Moderna’s mResvia (mRNA-1345) Gains the CHMP’s Positive Opinion to Prevent Lower Respiratory Tract Disease (LTRD)
June 27, 2024
Moderna Reports the P-III Study Data of mRNA-1283 Vaccine to Prevent COVID-19
June 14, 2024
Moderna Reports the P-III Study Data of mRNA-1083 Vaccine Against Influenza and COVID-19
June 11, 2024
Moderna Collaborates with OpenAI to Advance mRNA Medicine
April 26, 2024
Moderna and Merck Report Results from the P-IIb (KEYNOTE-942) Study of mRNA-4157 (V940) + Keytruda (pembrolizumab) for Resected Hi...
December 15, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.